Yunnan Jianzhijia Health-Chain Co., Ltd.

Shanghai Stock Exchange 605266.SS

Yunnan Jianzhijia Health-Chain Co., Ltd. Price to Earnings Ratio (P/E) on January 27, 2025: 8.21

Yunnan Jianzhijia Health-Chain Co., Ltd. Price to Earnings Ratio (P/E) is 8.21 on January 27, 2025, a -49.12% change year over year. Price to earnings ratio compares the stock price to earnings per share; higher P/E suggests expectations for future earnings growth.

Yunnan Jianzhijia Health-Chain Co., Ltd. 52-week high Price to Earnings Ratio (P/E) is 16.83 on May 14, 2024, which is 105.01% above the current Price to Earnings Ratio (P/E).
Yunnan Jianzhijia Health-Chain Co., Ltd. 52-week low Price to Earnings Ratio (P/E) is 5.80 on August 28, 2024, which is -29.28% below the current Price to Earnings Ratio (P/E).
Yunnan Jianzhijia Health-Chain Co., Ltd. average Price to Earnings Ratio (P/E) for the last 52 weeks is 10.51.

Key data

Date	Price to Earnings Ratio (P/E)	Price to Sales Ratio (P/S)	Price to Book Ratio (P/B)	Dividend Yield

Shanghai Stock Exchange: 605266.SS

Yunnan Jianzhijia Health-Chain Co., Ltd.

CEO	Mr. Bo Lan
IPO Date	Dec. 1, 2020
Location	China
Headquarters	Jianzhijia Office Building
Employees	16,649
Sector	Healthcare
Industries Drugstores & Retail Pharmacies Baby & Childcare Cleaning Supplies Cosmetics Eyewear Personal Care Pharmaceuticals

Description

Yunnan Jianzhijia Health-Chain Co., Ltd. engages in the pharmaceutical retail business in China. The company operates approximately 1,200 direct operated stores, as well as an online pharmacy business. It offers products in the areas of family medicine, contact lens/care solutions, medical instruments, sexual health, nutrition, Chinese herbal medicine, personal care, baby products, and convenience food. The company was founded in 2004 and is based in Kunming, China.

Key trends

Past 5 years